pembrolizumab
merck
['keynote-407']
5 years update keynote-407 phiii study presented by silvia novello at #esmo22. 
Predictive Molecular Pathology and Next Generation Technologies on Tissue and Liquid Biopsy. 
Tweet reflect my personal opinions!